Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubois, J.
Right arrow Articles by Yazbeck, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubois, J.
Right arrow Articles by Yazbeck, S.

Radiology, Vol 204, 651-654, Copyright © 1997 by Radiological Society of North America

ARTICLES

Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein

J Dubois, L Garel, A Abela, L Laberge and S Yazbeck
Department of Medical Imaging, Hopital Sainte-Justine, Montreal, Quebec, Canada.

PURPOSE: To determine the efficacy of percutaneous sclerotherapy with an alcoholic solution of zein in lymphangiomas in pediatric patients. MATERIALS AND METHODS: Fourteen patients with macrocystic and mixed lymphangiomas were treated with use of Ethibloc as a sclerosing agent. The procedure was performed with ultrasonographic and/or fluoroscopic guidance. Follow-up clinical and sequential computed tomographic examinations were performed to evaluate regression of the lesion. RESULTS: Regression was excellent in nine (64%) of the 14 lesions: Regression was complete in four lymphangiomas and was to less than 5% of the initial volume in five. Satisfactory results were obtained in the remaining five (36%) of 14 lesions. The most frequent complication was leakage of Ethibloc without important sequelae in 10 of the 14 lymphangiomas. CONCLUSION: Percutaneous sclerotherapy with Ethibloc was a safe and effective procedure in the treatment of macrocystic and mixed lymphangiomas.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
A. Desir, B. Ghaye, B. Duysinx, and R. F. Dondelinger
Percutaneous sclerotherapy of a giant mediastinal lymphangioma
Eur. Respir. J., September 1, 2008; 32(3): 804 - 806.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
C. M. Giguere, N. M. Bauman, Y. Sato, D. K. Burke, J. H. Greinwald, S. Pransky, P. Kelley, K. Georgeson, and R. J. H. Smith
Treatment of Lymphangiomas With OK-432 (Picibanil) Sclerotherapy: A Prospective Multi-institutional Trial
Arch Otolaryngol Head Neck Surg, October 1, 2002; 128(10): 1137 - 1144.
[Abstract] [Full Text] [PDF]

Home page
 ImagingHome page
D J Roebuck
Paediatric interventional radiology
Imaging, December 1, 2001; 13(4): 302 - 320.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
C Luzzatto, P Midrio, Z Tchaprassian, and M Guglielmi
Sclerosing treatment of lymphangiomas with OK-432
Arch. Dis. Child., April 1, 2000; 82(4): 316 - 318.
[Abstract] [Full Text]

Home page
 Am. J. Roentgenol.Home page
L. F. Donnelly, D. M. Adams, and G. S. Bisset III
Vascular Malformations and Hemangiomas: A Practical Approach in a Multidisciplinary Clinic
Am. J. Roentgenol., March 1, 2000; 174(3): 597 - 608.
[Full Text] [PDF]